This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

First Nepalese Conference On Hematology Organized By The Binaytara Foundation

KATHMANDU, Nepal, Sept. 15, 2013 /PRNewswire/ -- The International Conference on Advances in Hematologic Malignancies, held at the Yaki and Yeti Hotel in Kathmandu, Nepal, by the US-based Binaytara Foundation (BTF), concluded today. The President of BTF, Dr. Binay Shah, expressed his gratitude to the participants for contributing to the first meeting in hematology ever organized in Nepal. More than 30 speakers presented the newest findings in biology, genetics and therapy of leukemias and other hematologic malignancies. They also discussed current challenges in providing the best care for patients in developing countries.

The Binaytara Foundation (BTF) that promoted the conference announced on Saturday the recipients of the 2013 Annual BTF medical research grant. The following 4 investigators from multiple Nepalese hospitals were selected from a competitive pool of applicants: Pratigya Gyawali, Sumesh Khanal, Santosh Kumar Deo and Kedar Gautam. The goal of the BTF research grant project is to promote evidence-based medicine in the developing world. A recipient noted, "Being associated with BTF has been a great learning experience for me. As a recent research grant recipient of the foundation, I have been provided the opportunity that very few get so early in their career. The whole process of initiating and conducting research has widened my knowledge regarding evidence based medicine."

The conference established the basis for the development of common therapeutic strategies and clinical trials among Nepalese oncologists and members of the Binaytara Foundation (BTF), who will provide support in the development of a common treatment framework. Dr. Rajendra Baral, an oncologist from Kathmandu and the organizing secretary for the two-day conference, was awarded an honorary Binaytara Foundation membership.

Binaytara Foundation (BTF) is an Illinois-based, 501(c)3 non-profit organization. BTF charitable projects include medical research grants and the application of telemedicine to serve patients in third world countries. For more information on BTF projects, visit www.binayfoundation.org.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

SOURCE Binaytara Foundation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs